<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Photodynamic therapy (<z:chebi fb="7" ids="53228">PDT</z:chebi>) is used to treat <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and mucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Outcomes are variable with some patients having persistent disease, whereas others develop strictures </plain></SENT>
<SENT sid="2" pm="."><plain>The aims of this study were (a) to compare porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> tissue uptake, light dose, and esophageal thickness with clinical outcomes and (b) to determine the selectivity of porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> uptake in diseased and <z:mpath ids='MPATH_458'>normal</z:mpath> epithelium </plain></SENT>
<SENT sid="3" pm="."><plain>EXPERIMENTAL DESIGN: Forty-eight hours after porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> infusion, patients underwent mucosal biopsy for quantification of the porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Laser light was delivered at 48 hours and again 24 or 48 hours later </plain></SENT>
<SENT sid="5" pm="."><plain>Porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> was extracted from the biopsy samples and quantified using fluorescence spectroscopy </plain></SENT>
<SENT sid="6" pm="."><plain>The enhanced photodynamic dose was determined as [porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> content * light dose/esophageal thickness] </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="7" ids="53228">PDT</z:chebi> efficacy was determined 6 to 8 weeks later based on persistence or complete ablation of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Mean porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> content of 6.2 mg/kg (range, 2.6-11.2 mg/kg) and mean total light dose of 278 J/cm (range, 225-360 J/cm) resulted in a complete treatment </plain></SENT>
<SENT sid="9" pm="."><plain>Mean porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> tissue content of 3.9 mg/kg (range, 2.1-8.1 mg/kg) and mean total light dose of 268 J/cm (range, 250-350 J/cm) resulted in an incomplete treatment </plain></SENT>
<SENT sid="10" pm="."><plain>The total esophageal thickness (range, 1.7-6.0 mm) and enhanced photodynamic dose were correlated with treatment outcome </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Esophageal thickness is the strongest predictor of treatment outcome </plain></SENT>
<SENT sid="12" pm="."><plain>The porfimer <z:chebi fb="199" ids="26708">sodium</z:chebi> content of Barrett's and <z:mpath ids='MPATH_458'>normal</z:mpath> tissue is not significantly different. "Photodynamic dose" for esophageal <z:chebi fb="7" ids="53228">PDT</z:chebi> should incorporate the esophageal thickness </plain></SENT>
</text></document>